De-Escalation of Therapy for Low-Grade Papillary Bladder Tumors With Preserved Long-Term Oncologic Outcomes

被引：2

作者：

Herr, Harry ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10065 USA

来源：

UROLOGY PRACTICE | 2024年 / 11卷 / 05期

关键词：

low-grade papillary bladder tumors; fulguration;

D O I：

10.1097/UPJ.0000000000000631

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：777 / 780

页数：4

共 8 条

[1] European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) [J].

Babjuk, Marko ;

Burger, Maximilian ;

Capoun, Otakar ;

Cohen, Daniel ;

Comperat, Eva M. ;

Escrig, Jose L. Dominguez ;

Gontero, Paolo ;

Liedberg, Fredrik ;

Masson-Lecomte, Alexandra ;

Mostafid, A. Hugh ;

Palou, Joan ;

van Rhijn, Bas W. G. ;

Roupret, Morgan ;

Shariat, Shahrokh F. ;

Seisen, Thomas ;

Soukup, Viktor ;

Sylvester, Richard J. .

EUROPEAN UROLOGY, 2022, 81 (01) :75-94

[2] Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm [J].

Donat, SM ;

North, A ;

Dalbagni, G ;

Herr, HW .

JOURNAL OF UROLOGY, 2004, 171 (02) :636-639

[3] DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial [J].

Lindgren, Maria S. ;

Hansen, Erik ;

Azawi, Nessn ;

Nielsen, Anna M. ;

Dyrskjot, Lars ;

Jensen, Jorgen B. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :206-+

[4] Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG) [J].

Matulay, Justin T. ;

Soloway, Mark ;

Witjes, J. Alfred ;

Buckley, Roger ;

Persad, Raj ;

Lamm, Donald L. ;

Boehle, Andreas ;

Palou, Joan ;

Colombel, Marc ;

Brausi, Maurizio ;

Kamat, Ashish M. .

BJU INTERNATIONAL, 2020, 125 (04) :497-505

[5] Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence SWOG S0337 Randomized Clinical Trial [J].

Messing, Edward M. ;

Tangen, Catherine M. ;

Lerner, Seth P. ;

Sahasrabudhe, Deepak M. ;

Koppie, Theresa M. ;

Wood, David P., Jr. ;

Mack, Philip C. ;

Svatek, Robert S. ;

Evans, Christopher P. ;

Hafez, Haled S. ;

Culkin, Daniel J. ;

Brand, Timothy C. ;

Karsh, Lawrence I. ;

Holzbeierlein, Jeffrey M. ;

Wilson, Shandra S. ;

Wu, Guan ;

Plets, Melissa ;

Vogelzang, Nicholas J. ;

Thompson, Ian M., Jr. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18) :1880-1888

[6] Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder [J].

Rieken, Malte ;

Xylinas, Evanguelos ;

Kluth, Luis ;

Crivelli, Joseph J. ;

Chrystal, James ;

Faison, Talia ;

Lotan, Yair ;

Karakiewicz, Pierre I. ;

Holmang, Sten ;

Babjuk, Marek ;

Fajkovic, Harun ;

Seitz, Christian ;

Klatte, Tobias ;

Pycha, Armin ;

Bachmann, Alexander ;

Scherr, Douglas S. ;

Shariat, Shahrokh F. .

EUROPEAN UROLOGY, 2014, 65 (01) :201-209

[7]

Tan Wei Shen, 2023, Eur Urol, V83, P497, DOI 10.1016/j.eururo.2022.08.003

[8] Use of urinary biomarkers for bladder cancer surveillance: Patient perspectives [J].

Yossepowitch, Ofer ;

Herr, Harry W. ;

Donat, S. Machele .

JOURNAL OF UROLOGY, 2007, 177 (04) :1277-1282

← 1 →